Agilent has announced that it will acquire Genohm, a developer of highly differentiated, on-premise and cloud-based software solutions for laboratory management
Agilent Technologies has announced that it has signed an agreement to acquire Lasergen
Agilent Technologies has and BioTek Instruments, today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies
Agilent TechnologiesandImperial College London have signed a strategic scientific collaboration agreement that brings together Agilent’s analytical technologies with Imperial researchers
Agilent Technologies has announced it has acquired the UK-based Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety.
Agilent has released Cartagenia Bench Lab 5.0, a new version of its lab software with capabilities for somatic variant classification and reporting.
Agilent Technologies and Seahorse Bioscience has announced that they have signed a definitive agreement under which Agilent will acquire Seahorse Bioscience, a provider of instruments and assay kits for measuring cell metabolism and bioenergetics
Agilent Technologies has launched GeneSpring FX 10.0, the latest version of its flagship gene expression bioinformatics platform, now offering tools for systems-level data interpretation and pathway analysis.
The Kalabie Electronic Laboratory Notebook (ELN) is a paperless lab archive with a scalable, integrated platform for cross-team collaboration.
OpenLAB Enterprise Content Manager (ECM) is a software solution that helps users make better, faster decisions. By providing a secure, central repository and rich content services, ECM allows users to create, manage, collaborate, archive, and re-use all their business critical information with ease.
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
